Key Items to Consider for Your Municipality’s Next Technology Rollout

On There’s More to IT, host Jason Claybrook and guests will explore some foundational questions about the technology that’s driving us all forward.

Why do we build the stuff we build? What’s behind the scenes? Where are we falling short or putting revenue first?

The days of post-trade show drinks and conversation are far from over. In fact, they live right here on There’s More to IT.

 

The function of a city government has the most direct influence on residents and how that municipality manages budgets, revenue streams, and technology matters. To offer insights on how such a body functions, There’s More to It host Jason Claybrook conversed with Greg Giessner, City Councilman, and Steve Dye, Deputy City Manager, as well as co-hosts Simon Lok and Reid Estreicher. They both serve Grand Prairie, a city in the greater DFW area and home to around 200,000 citizens.

First, Giessner explained the upcoming bond vote. “It’s an economic development tool we’ve never had before. It would allow us to issue bonds for development projects for hotels, a conference center, restaurants, and revitalize downtown. It allows us to be competitive.”

“We’re a city that operates more like a business, and we’re always looking to generate revenue streams outside of property tax” -Greg Giessner

It’s an economic development tool we’ve never had before. It would allow us to issue bonds for development projects for hotels, a conference center, restaurants, and revitalize downtown. It allows us to be competitive.”

Dye also spoke about the power of technology in driving a city forward. It’s been a critical tool for law enforcement. “It improved efficiency and responsiveness but also offered savings. The immediate data entry is one key thing. We’re working smarter with technology because you can’t always throw people at the problem.”

The other aspect of technology is access. Dye noted the city is exploring options with the school districts about providing broadband for underserved communities. The pandemic and pivot to remote schooling were the catalysts for these considerations. “Connectivity is necessary for basic functions.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More